1
、tosyl imines 2 and allenes [3] [4] with different substituents were prepared according to literature procedures.
Instrumentation: All NMR spectra were run at 300 MHz ( 1 H NMR) or 500 MHz ( 13 C NMR) in CDCl3 solution. 1 H NMR spectra were internally referenced to TMS. 13 C NMR spectra were internally referenced to the residual solvent signal. Data for 1 H NMR are reported as follows:
chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m= multiplet, br = broad), coupling constants (J) were reported in Hz. High resolution mass spectra (HRMS) were recorded on Bruker MicrOTOF-QII mass instrument (ESI). 4 Prepared according to the methods of DolbierJr 1 and Kinoshita 2 .
General procedure for the preparation of sulfonyl formaldimines： 4-methyl-N-(phenylsulfonylmethyl)benzenesulfonamide
Formaldehyde (1.02 mL, 10.0 mmol, 1.0 equiv) was added to a stirring solution of ptoluenesulfonamide (1.71 g, 10.0 mmol, 1.0 equiv) and sodium phenylsulfinate (1.96 g, 11.0 mmol, 1.1 equiv) in formic acid and water (1:1, 30 mL) . After stirring for 12 h at room temperature, the reaction mixture was filtered under reduced pressure and then washed successively with water (50 mL) and hexane (50 mL), after air dry, the desired product was received (3.09 g, 95% yield 30, 136.69, 135.96, 134.54, 129.94, 129.36, 129.14, 126.82, 63.49, 21.58 ; HRMS (ESI) calcd. for C14H15KNO4S2 [M+K] :
364.0074, found: 364.0075. Observed data was consistent with that reported in the literature. The resulting 4-methyl-N-(phenylsulfonylmethyl)benzenesulfonamide was dissolved in DCE (100 mL) and saturated aqueous sodium bicarbonate solution (100 mL) was added. The resulting biphasic solution was vigorously stirred for 15 mins at rt, after which the organic layer was separated, dried (Na2SO4) and the solvent was filtered under reduced pressure to afford the 
General procedure for InCl3-catalyzed [2+2+2] cyclization of various alkenes and allenes with N-protected formaldimines：
An oven dried Schlenk tube was charged with catalyst InCl3 (20 mol %). The Schlenk tube was then evacuated and back filled with argon. The Teflon screw cap was replaced with a rubber septum and alkenes (1, 0.1 mmol) was added followed by sulfonyl imines 2 in dichloroethane solution (0.2 mol/L). The Schlenk tube was then purged with argon for 1 minute and the rubber septum was replaced with a Teflon screw cap. The reaction mixture was then stirred at 60 o C.
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After 12 h, the reaction mixture was purified by flash chromatography. For the slow addition protocol: a 10 mL screwtop vial was charged with the following substances: 2 (0.2 mol/L, 1.5 mL, 3 equiv), InCl3 (4.4 mg, 0.02 mmol, 0.2 equiv) and a magnetic stir bar. The vial was placed on a stir plate and stirred vigorously at room temperature while open to ambient atmosphere.
After the reaction temperature increased to 60 o C, a 1.0 mL glass syringe was charged with a solution of alkenes 1 (0.1 mmol, 1 equiv) in dichloroethane (1 mL, 0.1 M) and loaded into a syringe pump set with an addition rate of 0.33 mL/ h (0.0055 mL/min). The syringe was equipped with long needles and directed into the center of the uncapped vial, precautions should be taken not to touch the sides. The addition were initiated simultaneously added to the reaction vial over the course of 3 hours and go on stirring in the oil bath for another 9 hours. The crude mixture was concentrated via rotary evaporation to a minimal amount of dichloroethane and purified by flash chromatography. The fractions containing the product were collected and concentrated by rotary evaporation to afford the compound.
Experimental characterization data for hexahydropyrimidines (HHPs)：
4-phenyl-1, 3-ditosylhexahydropyrimidine (3a):
The title compound was prepared according to the general procedure as 143.97, 136.85, 136.71, 134.19, 129.97, 129.88, 128.91, 127.98, 127.57, 127.20, 126.85, 56.97, 53.43, 41.33, 24.81, 21.70, 21.54 98, 143.90, 137.33, 136.92, 134.33, 133.62, 129.95, 129.85, 129.58, 127.98, 127.20, 126.79, 56.89, 53.26, 41.32, 29.72, 24.79, 21.69, 21.54, 20.95 00, 143.94, 138.72, 136.92, 136.65, 134.34, 129.96, 129.85, 128.71, 128.33, 127.98, 127.61, 127.22, 123.73, 56.99, 53.45, 41.36, 24.88, 21.69, 21.56, 21.54 
4-(4-tert-butylphenyl)-1, 3-ditosylhexahydropyrimidine (3d):
The title compound was prepared according to the general procedure as yellow oil (32.7 mg, 62% yield 59, 143.92, 143.88, 136.95, 134.58, 133.66, 129.93, 129.84, 127.95, 127.27, 126.55, 125.80, 56.83, 53.34, 41.31, 34.44, 31.27, 25.02, 21.68, 21.53; HRMS (ESI) calcd. for C28H35N2O4S2 [M+H] : 527.2033, found: 527.2032.
1, 3-ditosyl-4-(4-(trifluoromethyl)phenyl)hexahydropyrimidine (3e):
The title compound was prepared according to the general procedure as white solid (48. 
4-(3-fluorophenyl)-1, 3-ditosylhexahydropyrimidine (3f):
The title compound was prepared according to the general procedure as colorless oil (48.4 mg, 99% yield). 1 H NMR (500 MHz, CDCl3) δ = 7.94 137.86, 134.92, 134.91, 131.61, 130.01, 129.86, 129.74, 128.70, 127.99, 127.84, 127.50, 126.93, 57.36, 54.02, 41.30, 27.97, 21.64, 21.62 
4-(4-bromophenyl)-1, 3-ditosylhexahydropyrimidine (3i):
The title compound was prepared according to the general procedure as white solid (52.5 mg, 96% yield, mp: 96. 24, 144.12, 136.60, 135.92, 133.95, 132.02, 130.05, 129.94, 128.71, 127.96, 127.17, 121.70, 56.98, 53.10, 41.25, 9 136.87, 134.16, 134.03, 133.14, 132.62, 130.03, 129.93, 128.91, 128.05, 128.02, 127.56, 127.13, 126.41, 126.39, 125.79, 124.93, 57.18, 53.63, 41.47, 24.69, 21.71 
Trans-5-methyl-4-phenyl-1, 3-ditosylhexahydropyrimidine (3n):
The title compound was prepared according to the general procedure as 10, 143.59, 138.68, 138.34, 136.27, 134.99, 129.99, 129.53, 128.76, 128.27, 127.77, 127.66, 127.58, 127.44, 126.94, 63.13, 56.98, 46.97, 45.73, 21.64, 21.58 ; HRMS (ESI) calcd. for Chemical Formula: C30H31N2O4S2
[M+H]: 547.1720, found: 547.1721.
1, 3-bis(naphthalen-2-ylsulfonyl)-4-phenylhexahydropyrimidine (3p):
The title compound was prepared according to the general procedure as white solid (37.5 mg, 69% yield, mp: 215. 136.70, 136.46, 135.13, 134.94, 134.33, 132.30, 132.22, 129.71, 129.60, 129.45, 129.29, 129.02, 128.96, 128.70, 128.02, 127.96, 127.72, 127.68, 127.58, 126.81, 123.11, 122.13, 57.04, 53.67, 41.38, 25.04 ; HRMS (ESI) calcd. for Chemical Formula: C30H26KN2O4S2
[M+K]: 581.0971, found: 581.0971.
1, 3-bis(mesitylsulfonyl)-4-phenylhexahydropyrimidine (3q):
The title compound was prepared according to the general procedure as colorless oil (30.9 mg, 59% yield, mp: 196.5-197.3 °C 141.08, 139.96, 137.11, 132.73, 132.09, 131.98, 130.79, 128.75, 127.54, 127.05, 54.84, 54.63, 40.47, 26.97, 22.96, 22.74, 21.08, 20.98 17, 143.92, 134.62, 134.60, 134.57, 129.78, 129.77, 129.68, 128.68, 128.47, 128.17, 127.84, 127.82, 125.26 
5-(4-methylbenzylidene)-1, 3-ditosylhexahydropyrimidine (5b):
The title compound was prepared according to the general procedure as colorless oil (32.3 mg, 65% yield). 1 H NMR (500 MHz, CDCl3) δ 12, 143.87, 137.73, 134.65, 134.54, 131.75, 129.76, 129.64, 129.17, 128.62, 128.14, 127.88, 124.57, 61.48, 52.20, 45.85, 21.62, 21.55, 21.25 ; HRMS (ESI) calcd. for
Chemical Formula: C26H28N2NaO4S2 [M+Na]: 519.1383, found: 519.1383.
5-(3-methylbenzylidene)-1, 3-ditosylhexahydropyrimidine (5c):
The title compound was prepared according to the general procedure as colorless oil (20.9 mg, 42% yield). 11, 143.88, 138.05, 134.69, 134.58, 129.94, 129.75, 129.66, 129.46, 128.55, 128.34, 128.21, 127.84, 125.69, 125.04, 61.54, 52.25, 45.93, 21.62, 21.54, 21.42 
5-(2, 4-dimethylbenzylidene)-1, 3-ditosylhexahydropyrimidine (5d):
The title compound was prepared according to the general procedure as white solid (27.6 mg, 54% yield, mp: 157.4-159.5 °C 144.08, 143.86, 137.87, 136.22, 135.01, 134.45, 130.88, 130.51, 129.79, 129.76, 128.84, 128.57, 128.17, 127.69, 126.42, 125.01, 61.44, 52.09, 46.08, 21.59, 21.57, 21.13, 19.68 ; HRMS (ESI) calcd. for Chemical Formula: C27H31N2O4S2 [M+H]: 511.1720, found: 511.1723.
5-(4-chlorobenzylidene)-1, 3-ditosylhexahydropyrimidine (5e):
The title compound was prepared according to the general procedure as yellow solid (49. 1 mg, 95% yield, mp: 191.7-192.3 °C 144.19, 144.07, 134.74, 134.42, 133.77, 133.02, 129.94, 129.74, 128.71, 128.52, 128.23, 127.79, 126.14, 61.48, 52.13, 45.75, 21.62, 21.56 144.20, 144.09, 134.74, 134.40, 133.49, 131.65, 130.24, 129.75, 128.55, 128.23, 127.78, 126.20, 121.92, 61.48, 52.13, 45.75, 21.63, 21.57 13, 135.00, 134.12, 133.71, 132.77, 130.46, 129.91, 129.79, 129.59, 129.34, 128.28, 127.59, 126.92, 126.79, 126.64, 61.45, 51.98, 46.11, 21.63, 21.55 140.85, 136.31, 135.96, 133.91, 129.73, 129.56, 128.33, 128.28, 127.63, 127.60, 127.44, 119.58, 61.49, 48.09, 46.88, 21.57, 20.59 07, 143.86, 136.16, 134.60, 133.70, 129.92, 129.74, 129.50, 128.73, 128.51, 128.38, 127.88, 127.55, 127.49, 55.94, 55.87, 42.15, 21.60, 21.50, 18.64 The E configuration of the major isomer was determined by NOESY experiment.
Isolation of N-cinnamyl-4-methylbenzenesulfonamide (6) in an interrupted reaction:
An oven dried Schlenk tube was charged with catalyst InCl3 (10 mol %). The Schlenk tube was then evacuated and back filled with argon. The Teflon screw cap was replaced with a rubber septum and alkenes (1, 0.1 mmol) was added followed by sulfonyl imines 2 in dichloroethane solution (0.2 mol/L). The Schlenk tube was then purged with argon for 1 minute and the rubber septum was replaced with a Teflon screw cap. The reaction mixture was then stirred at 60 o C.
After 12 h, the reaction mixture was purified by flash chromatography. Then got the desired product with 15% isolated yield.
N-cinnamyl-4-methylbenzenesulfonamide (6):
The title compound was prepared according to the method mentioned above as light yellow oil (4.3 mg, 15% yield). 59, 137.12, 136.09, 133.15, 129.79, 128.59, 127.99, 127.24, 126.43, 124.08, 45.54, 21.53 . This compound has previously 17 been reported 5 and its structure has been confirmed by comparison with the published spectral data. The title compound was prepared according to the general procedure as white solid (45.3 mg, 88% yield, mp: 144.0-146.7 °C). 1 H NMR (300
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